Fanrong Kong

Fanrong Kong is a Senior Scientist at Pfizer, with prior experience as a Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson and as a Postdoctoral Fellow at Albert Einstein College of Medicine. Kong's research projects include the expression, purification, and structural determination of the cardiac potassium channel KCNQ1 (Kv7.1) in relation to Long QT Syndrome. Academic qualifications include a Ph.D. in Biology from the Massachusetts Institute of Technology and a Bachelor's Degree in Biological Sciences from Cornell University.